Wedbush Expects Increased Earnings for Viridian Therapeutics
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Analysts at Wedbush lifted their Q1 2025 earnings per share estimates for Viridian Therapeutics in a report released on Thursday, February 27th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($1.01) for the quarter, up from their prior estimate of […]
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Analysts at Wedbush lifted their Q1 2025 earnings per share estimates for Viridian Therapeutics in a report released on Thursday, February 27th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($1.01) for the quarter, up from their prior estimate of […]
